Sonosensitive capsules for brain thrombolysis increase ischemic damage in a stroke model

BACKGROUND: Ischemic stroke is the most common cerebrovascular disease and is caused by interruption of blood supply to the brain. To date, recombinant tissue plasminogen activator (rtPA) has been the main pharmacological treatment in the acute phase. However, this treatment has some drawbacks, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Correa-Paz, Clara, Navarro Poupard, María F., Polo, Ester, Rodríguez-Pérez, Manuel, Migliavacca, Martina, Iglesias-Rey, Ramón, Ouro, Alberto, Maqueda, Elena, Hervella, Pablo, Sobrino, Tomás, Castillo, José, del Pino, Pablo, Pelaz, Beatriz, Campos, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780814/
https://www.ncbi.nlm.nih.gov/pubmed/35062954
http://dx.doi.org/10.1186/s12951-022-01252-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780814/
https://www.ncbi.nlm.nih.gov/pubmed/35062954
http://dx.doi.org/10.1186/s12951-022-01252-9

Ejemplares similares